Abbott profit rises, but drug sales lag

Article Abstract:

Abbott Laboratories posted a 9.8% improvement in its earnings for the second-quarter of 1999. The company posted the higher earnings despite the fact that its pharmaceutical division's sales declined. Abbott's earnings matched what analysts had predicted. For the quarter, the company reported an net income increase to $642.7 million ($631.5 million euros). Abbott's sales also rose 5.8% to $3.24 billion.

Comment:

Posts 9.8% improvement in earnings for second-quarter of 1999

Abstract

---

Pharmacia affirms intent to boost earnings by 20%

Article Abstract:

Pharmacia Corp. announced that it was intent on raising by at least 20% its earnings target for the 2001 year. The company made this commitment despite the policy challenges taking place in the pharmaceutical industry.

PNU, Pharmacia Corp.

---

Abbott net fell 23% in second quarter after Knoll charge

Article Abstract:

Abbott Laboratories posted a decline of 23% in its net for the 2001 second-quarter. The result came after a higher-than-expected charge of $6.9 billion for the company's acquisition of Knoll Pharmaceutical.

ABT

Similar abstracts:

• Abstracts: Campbell Soup profit falls but sales beat expectations. General Mills posts 18% rise in 1st-quarter net income
• Abstracts: China's prospects lifted equity funds in second quarter. Pickerell stays on course
• Abstracts: Flagship unit hurts profit at Berkshire. Berkshire's net strengthened 21% in latest quarter. Tokio Marine's net rises 22%, aided by cost reductions
• Abstracts: Airbus struggles to nail down Chinese order. Airbus gets boost from order for 29 jets from Singapore Air. Swissair will pay AOM/Air Liberte E228.7 million
• Abstracts: LVMH expects annual profit to fall between 10% and 15%. Prada agrees to sell Fendi interest to LVMH. LVMH slightly exceeds sales estimates

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.